Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Shigeko Inokuma. (2022) Search of official nationwide database in Japan for adverse events associated with disease-modifying antirheumatic drug therapies: focus on therapies in combination with methotrexate. Expert Opinion on Drug Safety 21:4, pages 573-580.
Read now
Read now
Yasuo Suzuki, Naonobu Sugiyama, Yuri Fukuma, Noriko Sugiyama & Takeshi Kokubo. (2020) Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: a postmarketing surveillance report. Modern Rheumatology 30:1, pages 24-35.
Read now
Read now
Tsutomu Takeuchi, Kota Ishida, Katsuhisa Shiraki & Takashi Yoshiyasu. (2018) Safety and effectiveness of tacrolimus add-on therapy for rheumatoid arthritis patients without an adequate response to biological disease-modifying anti-rheumatic drugs (DMARDs): Post-marketing surveillance in Japan. Modern Rheumatology 28:1, pages 48-57.
Read now
Read now
Ayako Nakajima, Eisuke Inoue, Atsuo Taniguchi, Shigeki Momohara & Hisashi Yamanaka. (2016) Effectiveness of tacrolimus in comparison with methotrexate or biologics in propensity score-matched patients with rheumatoid arthritis. Modern Rheumatology 26:6, pages 836-843.
Read now
Read now
Hiroyuki Nakamura, Toshio Odani, Yuka Shimizu, Tsuyoshi Takeda & Hideaki Kikuchi. (2016) Usefulness of tacrolimus for refractory adult-onset still's disease: Report of six cases. Modern Rheumatology 26:6, pages 963-967.
Read now
Read now
Takenori Niioka, Atsushi Komatsuda, Shotaro Kato, Masaru Togashi, Shin Okuyama, Ayumi Omokawa, Mizuho Nara, Hideki Wakui, Naoto Takahashi & Masatomo Miura. (2015) Effects of CYP3A5 polymorphism and the tacrolimus 12 h concentration on tacrolimus-induced acute renal dysfunction in patients with lupus nephritis. Xenobiotica 45:12, pages 1147-1153.
Read now
Read now
Articles from other publishers (18)
Tsuneyuki Oda, Hideya Kitamura, Koji Okudela, Tamiko Takemura & Takashi Ogura. (2023) Very-late-onset interstitial pneumonia suspected to be related to liver transplantation more than 10 years ago. Respiratory Investigation 61:6, pages 682-686.
Crossref
Crossref
Kenya Terabe, Nobunori Takahashi, Shuji Asai, Yuji Hirano, Yasuhide Kanayama, Yuichiro Yabe, Takeshi Oguchi, Takayoshi Fujibayashi, Hisato Ishikawa, Masahiro Hanabayashi, Yosuke Hattori, Mochihito Suzuki, Kenji Kishimoto, Yoshifumi Ohashi, Takahiro Imaizumi, Shiro Imagama & Toshihisa Kojima. (2023) Effectiveness of tacrolimus concomitant with biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Modern Rheumatology 33:2, pages 292-301.
Crossref
Crossref
Na Cha, Naoki Oshima, Kenichi Kishimoto, Satoshi Kotani, Eiko Okimoto, Tomotaka Yazaki, Hiroki Sonoyama, Akihiko Oka, Yoshiyuki Mishima, Kotaro Shibagaki, Hiroshi Tobita, Kousaku Kawashima, Norihisa Ishimura & Shunji Ishihara. (2022) Long-lasting renal dysfunction following tacrolimus induction therapy in ulcerative colitis patients. Journal of Clinical Biochemistry and Nutrition 70:3, pages 297-303.
Crossref
Crossref
Hironari Hanaoka, Jun Kikuchi, Yuko Kaneko, Noriyasu Seki, Hideto Tsujimoto, Kenji Chiba & Tsutomu Takeuchi. (2021) Proton Pump Inhibitor and Tacrolimus Uses are Associated With Hypomagnesemia in Connective Tissue Disease: a Potential Link With Renal Dysfunction and Recurrent Infection. Frontiers in Pharmacology 12.
Crossref
Crossref
Tsutomu Takeuchi, Naoko Wakasugi, Satoshi Uno & Hirofumi Makino. (2021) Long-term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis: 5-year Interim Postmarketing Surveillance Study in Japan (TRUST). The Journal of Rheumatology 48:1, pages 74-81.
Crossref
Crossref
Masaaki Higashiyama, Akira Sugita, Kazutaka Koganei, Kenji Wanatabe, Yoko Yokoyama, Motoi Uchino, Masakazu Nagahori, Makoto Naganuma, Shigeki Bamba, Shingo Kato, Ken Takeuchi, Teppei Omori, Tomohisa Takagi, Satohiro Matsumoto, Mitsuo Nagasaka, Shintaro Sagami, Kazuya Kitamura, Takehiko Katsurada, Ken Sugimoto, Noritaka Takatsu, Masayuki Saruta, Toshiyuki Sakurai, Kazuhiro Watanabe, Shiro Nakamura, Yasuo Suzuki & Ryota Hokari. (2019) Management of elderly ulcerative colitis in Japan. Journal of Gastroenterology 54:7, pages 571-586.
Crossref
Crossref
Hamid Reza Tavakoli, Mehdi Naderi, Seid Mahdi Jafari & Mohammad Hossein Naeli. (2019) Postmarketing surveillance of the oxidative stability for cooking oils, frying oils, and vanaspati supplied in the retail market. Food Science & Nutrition 7:4, pages 1455-1465.
Crossref
Crossref
Eun-Young Park, Seung-Geun Lee, Eun-Kyoung Park, Dong-Wan Koo, Ji-Heh Park, Geun-Tae Kim, Hee-Sang Tag, Hyun-Ok Kim & Young-Sun Suh. (2018) Drug survival and the associated predictors in South Korean patients with rheumatoid arthritis
receiving tacrolimus. The Korean Journal of Internal Medicine 33:1, pages 193-202.
Crossref
Crossref
Hideto Kameda. 2018. Drug-Induced Lung Injury. Drug-Induced Lung Injury
165
176
.
Kentaro Noda, Taro Ukichi, Kazuhiro Furuya, Ken Yoshida, Isamu Kingetsu, Toshikazu Tanaka & Daitaro Kurosaka. (2017) Tacrolimus-induced hypertrophic cardiomyopathy in a patient with dermatomyositis. Rheumatology 56:11, pages 2037-2038.
Crossref
Crossref
Kiyoshi Migita, Yukihiro Akeda, Manabu Akazawa, Shigeto Tohma, Fuminori Hirano, Haruko Ideguchi, Ryutaro Matsumura, Eiichi Suematsu, Tomoya Miyamura, Shunsuke Mori, Takahiro Fukui, Yasumori Izumi, Nozomi Iwanaga, Hiroshi Tsutani, Kouichirou Saisyo, Takao Yamanaka, Shiro Ohshima, Takao Sugiyama, Yojiro Kawabe, Masao Katayama, Yasuo Suenaga, Akira Okamoto, Hisaji Ohshima, Yasumasa Okada, Kenji Ichikawa, Shigeru Yoshizawa, Kenji Kawakami, Toshihiro Matsui, Hiroshi Furukawa & Kazunori Oishi. (2015) Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus. Arthritis Research & Therapy 17:1.
Crossref
Crossref
Kota Ishida, Katsuhisa Shiraki & Takashi Yoshiyasu. (2015) Evaluation of the Safety and Effectiveness of Add-On Tacrolimus in Patients with Rheumatoid Arthritis Who Failed to Show an Adequate Response to Biological DMARDs: The Interim Results of a Specific Drug Use-Results Survey of Tacrolimus. Drugs in R&D 15:4, pages 307-317.
Crossref
Crossref
Nobunori Takahashi, Takayoshi Fujibayashi, Daihei Kida, Yuji Hirano, Takefumi Kato, Daizo Kato, Kiwamu Saito, Atsushi Kaneko, Yuichiro Yabe, Hideki Takagi, Takeshi Oguchi, Hiroyuki Miyake, Tsuyoshi Watanabe, Masatoshi Hayashi, Yasuhide Kanayama, Koji Funahashi, Masahiro Hanabayashi, Shinya Hirabara, Shuji Asai, Toki Takemoto, Kenya Terabe, Nobuyuki Asai, Yutaka Yoshioka, Naoki Ishiguro & Toshihisa Kojima. (2015) Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use. Rheumatology International 35:10, pages 1707-1716.
Crossref
Crossref
Chak Sing Lau, Faith Chia, Andrew Harrison, Tsu‐Yi Hsieh, Rahul Jain, Seung Min Jung, Mitsumasa Kishimoto, Ashok Kumar, Khai Pang Leong, Zhanguo Li, Juan Javier Lichauco, Worawit Louthrenoo, Shue‐Fen Luo, Peter Nash, Chin Teck Ng, Sung‐Hwan Park, Bagus Putu Putra Suryana, Parawee Suwannalai, Linda Kurniaty Wijaya, Kazuhiko Yamamoto, Yue Yang & Swan Sim Yeap. (2015)
APLAR
rheumatoid arthritis treatment recommendations
. International Journal of Rheumatic Diseases 18:7, pages 685-713.
Crossref
Crossref
Masaru Togashi, Takenori Niioka, Atsushi Komatsuda, Mizuho Nara, Shin Okuyama, Ayumi Omokawa, Maiko Abumiya, Hideki Wakui, Naoto Takahashi & Masatomo Miura. (2015) Effect of CYP3A5 and ABCB1 polymorphisms on the interaction between tacrolimus and itraconazole in patients with connective tissue disease. European Journal of Clinical Pharmacology 71:9, pages 1091-1097.
Crossref
Crossref
Masaki Shimizu, Kazuyuki Ueno, Sayaka Ishikawa, Yuko Tokuhisa, Natsumi Inoue & Akihiro Yachie. (2014) Treatment of refractory polyarticular juvenile idiopathic arthritis with tacrolimus. Rheumatology 53:11, pages 2120-2122.
Crossref
Crossref
Kosuke Tanaka, Chikashi Terao, Koichiro Ohmura, Meiko Takahashi, Ran Nakashima, Yoshitaka Imura, Hajime Yoshifuji, Naoichiro Yukawa, Takashi Usui, Takao Fujii, Tsuneyo Mimori & Fumihiko Matsuda. (2013) Significant association between CYP3A5 polymorphism and blood concentration of tacrolimus in patients with connective tissue diseases. Journal of Human Genetics 59:2, pages 107-109.
Crossref
Crossref
In Suk MinYeonMi JuHyun-young KimYun Jung ChoiWon-Seok LeeWan-Hee Yoo. (2014) Hemorrhagic Cystitis with Giant Cells in Rheumatoid Arthritis Treating with Tacrolimus. Journal of Rheumatic Diseases 21:6, pages 336.
Crossref
Crossref